NeoGenomics Inc (NEO) NPV

Sell:$10.90Buy:$11.25$0.76 (6.41%)

Prices delayed by at least 15 minutes
Sell:$10.90
Buy:$11.25
Change:$0.76 (6.41%)
Deal now
Prices delayed by at least 15 minutes
Sell:$10.90
Buy:$11.25
Change:$0.76 (6.41%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

Key people

Christopher M. Smith
Chief Executive Officer, Director
Jeffrey Scott Sherman
Chief Financial Officer
Vishal Sikri
President - Advanced Diagnostics
Melody Harris
Chief Operating Officer, President - Informatics
Alicia Olivo
EVP, General Counsel & Business Development
Gregory Aunan
Chief Accounting Officer
Warren Stone
Chief Commercial Officer
Lynn A. Tetrault
Independent Chairman of the Board
Michael A. Kelly
Lead Independent Director
Bruce K. Crowther
Independent Director
Elizabeth Floegel
Independent Director
Neil Gunn
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • ISIN
    US64049M2098
  • Market cap
    $1.63bn
  • Employees
    2,200
  • Shares in issue
    128.46m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.